Novel biomarkers in heart failure with preserved ejection fraction - PubMed (original) (raw)
Review
Novel biomarkers in heart failure with preserved ejection fraction
Kevin S Shah et al. Heart Fail Clin. 2014 Jul.
Abstract
Heart failure with preserved ejection fraction (HFPEF) is a common subtype of heart failure with morbidity and mortality similar to that of heart failure with systolic dysfunction. This article discusses the numerous biomarkers that promise to play a substantial role in terms of our ability to understand the mechanisms of HFPEF and discern possible phenotypes that respond to targeted therapies: natriuretic peptides, high-sensitivity troponins, galectin-3, soluble ST2, neutrophil gelatinase-associated lipocalin, and cystatin C.
Keywords: Biomarkers; Diagnosis; Heart failure; Preserved ejection fraction; Prognosis.
Published by Elsevier Inc.
Similar articles
- Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R, Chong JP, Ng TP, Ling LH, Sim D, Leong KT, Yeo PS, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Richards AM, Lam CS. Santhanakrishnan R, et al. Eur J Heart Fail. 2012 Dec;14(12):1338-47. doi: 10.1093/eurjhf/hfs130. Epub 2012 Aug 5. Eur J Heart Fail. 2012. PMID: 22869458 - Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review.
Garg A, Virmani D, Agrawal S, Agarwal C, Sharma A, Stefanini G, Kostis JB. Garg A, et al. Cardiology. 2017;136(3):192-203. doi: 10.1159/000450573. Epub 2016 Oct 27. Cardiology. 2017. PMID: 27784010 Review. - Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction.
Gruson D, Lepoutre T, Ahn SA, Rousseau MF. Gruson D, et al. Int J Cardiol. 2014;172(1):e250-2. doi: 10.1016/j.ijcard.2013.12.101. Epub 2014 Jan 4. Int J Cardiol. 2014. PMID: 24467978 No abstract available. - Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A, de Antonio M, Vila J, Peñafiel J, Galán A, Barallat J, Zamora E, Urrutia A, Lupón J. Bayes-Genis A, et al. J Am Coll Cardiol. 2014 Jan 21;63(2):158-66. doi: 10.1016/j.jacc.2013.07.087. Epub 2013 Sep 24. J Am Coll Cardiol. 2014. PMID: 24076531 - Can biomarkers help to diagnose early heart failure with preserved ejection fraction?
Meluzín J, Tomandl J. Meluzín J, et al. Dis Markers. 2015;2015:426045. doi: 10.1155/2015/426045. Epub 2015 Jan 31. Dis Markers. 2015. PMID: 25802475 Free PMC article. Review.
Cited by
- Rehabilitation Enablement in Chronic Heart Failure-a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trial.
Eyre V, Lang CC, Smith K, Jolly K, Davis R, Hayward C, Wingham J, Abraham C, Green C, Warren FC, Britten N, Greaves CJ, Doherty P, Austin J, Van Lingen R, Singh S, Buckingham S, Paul K, Taylor RS, Dalal HM; REACH-HF investigators. Eyre V, et al. BMJ Open. 2016 Oct 25;6(10):e012853. doi: 10.1136/bmjopen-2016-012853. BMJ Open. 2016. PMID: 27798024 Free PMC article. Clinical Trial. - Differentiating pulmonary transfusion reactions using recipient and transfusion factors.
Roubinian NH, Looney MR, Keating S, Kor DJ, Lowell CA, Gajic O, Hubmayr R, Gropper M, Koenigsberg M, Wilson GA, A Matthay M, Toy P, Murphy EL; TRALI Study Group. Roubinian NH, et al. Transfusion. 2017 Jul;57(7):1684-1690. doi: 10.1111/trf.14118. Epub 2017 May 3. Transfusion. 2017. PMID: 28470756 Free PMC article. - Biomarkers in heart failure: the past, current and future.
Sarhene M, Wang Y, Wei J, Huang Y, Li M, Li L, Acheampong E, Zhengcan Z, Xiaoyan Q, Yunsheng X, Jingyuan M, Xiumei G, Guanwei F. Sarhene M, et al. Heart Fail Rev. 2019 Nov;24(6):867-903. doi: 10.1007/s10741-019-09807-z. Heart Fail Rev. 2019. PMID: 31183637 Review. - Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers.
Berezin AE. Berezin AE. J Circ Biomark. 2016 Mar 16;5:6. doi: 10.5772/62797. eCollection 2016 Jan-Dec. J Circ Biomark. 2016. PMID: 28936254 Free PMC article. Review. - Thymosin Beta-4 Is Elevated in Women With Heart Failure With Preserved Ejection Fraction.
Drum CL, Tan WKY, Chan SP, Pakkiri LS, Chong JPC, Liew OW, Ng TP, Ling LH, Sim D, Leong KG, Yeo DPS, Ong HY, Jaufeerally F, Wong RCC, Chai P, Low AF, Davidsson P, Liljeblad M, Söderling AS, Gan LM, Bhat RV, Purnamawati K, Lam CSP, Richards AM. Drum CL, et al. J Am Heart Assoc. 2017 Jun 13;6(6):e005586. doi: 10.1161/JAHA.117.005586. J Am Heart Assoc. 2017. PMID: 28611096 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical